These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62. Urogynecologic complications in Stevens-Johnson syndrome and toxic epidermal necrolysis: Presentation of a case and recommendations for management. Petukhova TA; Maverakis E; Ho B; Sharon VR JAAD Case Rep; 2016 May; 2(3):202-5. PubMed ID: 27274537 [No Abstract] [Full Text] [Related]
63. Stevens-Johnson syndrome/toxic epidermal necrolysis mouse model generated by using PBMCs and the skin of patients. Saito N; Yoshioka N; Abe R; Qiao H; Fujita Y; Hoshina D; Suto A; Kase S; Kitaichi N; Ozaki M; Shimizu H J Allergy Clin Immunol; 2013 Feb; 131(2):434-41.e1-9. PubMed ID: 23111236 [TBL] [Abstract][Full Text] [Related]
64. Stevens-Johnson syndrome and toxic epidermal necrolysis in patients with lupus erythematosus: a descriptive study of 17 cases from a national registry and review of the literature. Ziemer M; Kardaun SH; Liss Y; Mockenhaupt M Br J Dermatol; 2012 Mar; 166(3):575-600. PubMed ID: 22014091 [TBL] [Abstract][Full Text] [Related]
66. A decade of burn unit experience with Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: Clinical pathological diagnosis and risk factor awareness. Lim VM; Do A; Berger TG; Nguyen AH; DeWeese J; Malone JD; Jordan K; Hom F; Tuffanelli L; Fillari P; Siu S; Grossman R Burns; 2016 Jun; 42(4):836-43. PubMed ID: 26847613 [TBL] [Abstract][Full Text] [Related]
67. Analysis of the acute ophthalmic manifestations of the erythema multiforme/Stevens-Johnson syndrome/toxic epidermal necrolysis disease spectrum. Power WJ; Ghoraishi M; Merayo-Lloves J; Neves RA; Foster CS Ophthalmology; 1995 Nov; 102(11):1669-76. PubMed ID: 9098260 [TBL] [Abstract][Full Text] [Related]
68. Racial disparities in the risk of Stevens-Johnson Syndrome and toxic epidermal necrolysis as urate-lowering drug adverse events in the United States. Lu N; Rai SK; Terkeltaub R; Kim SC; Menendez ME; Choi HK Semin Arthritis Rheum; 2016 Oct; 46(2):253-258. PubMed ID: 27217070 [TBL] [Abstract][Full Text] [Related]
69. Pediatric SJS-TEN: Where are we now? Ramien M; Goldman JL F1000Res; 2020; 9():. PubMed ID: 32850118 [TBL] [Abstract][Full Text] [Related]
70. Delayed Stevens-Johnson Syndrome Secondary to the Use of Lamotrigine in Bipolar Mood Disorder. Jha KK; Chaudhary DP; Rijal T; Dahal S Indian J Psychol Med; 2017; 39(2):209-212. PubMed ID: 28515564 [TBL] [Abstract][Full Text] [Related]
71. Spontaneous adverse event reports of Stevens-Johnson syndrome/toxic epidermal necrolysis: detecting associations with medications. Papay J; Yuen N; Powell G; Mockenhaupt M; Bogenrieder T Pharmacoepidemiol Drug Saf; 2012 Mar; 21(3):289-96. PubMed ID: 22139991 [TBL] [Abstract][Full Text] [Related]
72. Adverse drug reaction causality assessment tools for drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: room for improvement. Goldman JL; Chung WH; Lee BR; Chen CB; Lu CW; Hoetzenecker W; Micheletti R; Yasuda SU; Margolis DJ; Shear NH; Struewing JP; Pirmohamed M Eur J Clin Pharmacol; 2019 Aug; 75(8):1135-1141. PubMed ID: 30918988 [TBL] [Abstract][Full Text] [Related]
73. Toxic epidermal necrolysis induced by lamotrigine treatment in a child. Yi Y; Lee JH; Suh ES Korean J Pediatr; 2014 Mar; 57(3):153-6. PubMed ID: 24778698 [TBL] [Abstract][Full Text] [Related]
79. Central Pontine Myelinolysis in a Normonatremic Patient with Depression. Liu YC; Yang YK; Chen PS; Chang WH Clin Psychopharmacol Neurosci; 2021 Aug; 19(3):564-567. PubMed ID: 34294627 [TBL] [Abstract][Full Text] [Related]
80. Photodistributed Stevens-Johnson syndrome and toxic epidermal necrolysis: a systematic review and proposal for a new diagnostic classification. McKinley BJ; Allen ME; Michels N Eur J Med Res; 2023 Jun; 28(1):188. PubMed ID: 37303053 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]